X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.pharmaceutical-technology.com/news/medsenic-licence-phebra-oato/
https://www.globenewswire.com/news-release/2022/11/08/2550394/0/en/BioSenic-SA-provides-update-on-its-autoimmune-disease-platform-based-on-ATO-arsenic-trioxide.html
https://www.europeanpharmaceuticalreview.com/news/165376/drug-combination-an-alternative-leukaemia-treatment-to-chemotherapy/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214011
https://www.ema.europa.eu/documents/overview/arsenic-trioxide-medac-epar-medicine-overview_en.pdf
https://www.ema.europa.eu/en/documents/overview/arsenic-trioxide-medac-epar-medicine-overview_en.pdf
https://www.raps.org/news-and-articles/news-articles/2020/7/ema-thumbs-up-for-11-down-for-2-new-medicines
https://www.ema.europa.eu/en/documents/assessment-report/arsenic-trioxide-mylan-epar-public-assessment-report_en.pdf
https://www.prnewswire.com/news-releases/flexipharm-austrading-announces-product-update-on-arsenic-trioxide-phebra-301027637.html
https://www.bccourier.com/global-pharmaceutical-grade-arsenic-trioxide-market-2020-growth-latest-trend-analysis-and-forecast-2025/
http://www.pharmatimes.com/news/xospata_leads_latest_chmp_recommendations_1302120
https://www.raps.org/news-and-articles/news-articles/2019/9/emas-chmp-recommends-three-new-medicines
http://www.pharmatimes.com/news/darzalex,_ibrance_among_latest_smc_decisions_1294142
https://www.phebra.com/wp-content/uploads/2019/05/ATO_Phebra-Media-Release_Canada.pdf
https://www.prnewswire.com/news-releases/flexipharm-austrading-announces-launch-of-arsenic-trioxide-phebra-arsenic-trioxide-1mgml-concentrate-for-solution-for-infusion-300853052.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209873
https://en.prnasia.com/releases/global/world-first-development-of-an-arsenic-peptide-to-target-cancer-242660.shtml
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209780
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206228
https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-usfda-nod-for-leukemia-treatment-injection/66619008
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210802
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208231
https://www.prnewswire.com/news-releases/cti-biopharma-to-receive-10-million-milestone-payment-for-trisenox-300584322.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078064
http://www.europeanpharmaceuticalreview.com/45961/news/industry-news/ec-approves-tevas-acute-promyelocytic-leukaemia-drug/
http://www.pharmatimes.com/news/eu_expands_scope_of_tevas_trisenox_1177797
Market Place
Share 
